MLi-2
MLi-2, a chemical probe, is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0.76 nM. MLi-2 has the potential for Parkinson’s disease[1].
Product Specifications
CAS Number
1627091-47-7
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LRRK2
Type
Reference compound
Related Pathways
Autophagy
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/MLi-2.html
Purity
99.80
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C[C@@](C1)([H])O[C@](C)([H])CN1C2=CC(C3=NNC4=CC=C(OC5(C)CC5)C=C43)=NC=N2
Molecular Formula
C21H25N5O2
Molecular Weight
379.46
Precautions
H302, H315, H319, H335
References & Citations
[1]Fell MJ, et al. MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition. J Pharmacol Exp Ther. 2015 Dec;355 (3) :397-409.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL317074V 500 µL Each
OSBPL3 Human shRNA Lentiviral Particle (Locus ID 26031)
Sign In for Pricing
View Details